<DOC>
	<DOCNO>NCT00817063</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy alitretinoin treatment severe chronic hand eczema respond treatment potent topical steroid .</brief_summary>
	<brief_title>Efficacy Safety Retinoid Treatment Severe Chronic Hand Eczema</brief_title>
	<detailed_description>Chronic hand eczema ( CHE ) distress disease pose difficult problem dermatologist . CHE lead considerable work-absenteeism , disability exclusion labour market . Conventional treatment , include highly potent topical steroid , yield often unsatisfactory result . This study investigate efficacy safety oral alitretinoin , retinoid , patient respond avoidance causative factor , contact allergen skin irritant , non-medicated skin care highly potent topical steroid . Eligible patient randomly assign receive alitretinoin placebo .</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>type chronic hand eczema , last least 6 month since initial diagnosis rat severe physician unresponsive highly potent topical corticosteroid , clobetasol patient whose disease adequately control standard nonmedicated therapy , include potent topical steroid , skin moisturizers , avoidance allergen irritant patient know allergens irritant , make reasonable effort avoid substances patient psoriasis lesion active fungal , bacterial viral infection hand female patient pregnant breastfeed female patient childbearing potential use commit use two effective method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>retinoid treatment</keyword>
	<keyword>fingertip dermatitis</keyword>
	<keyword>hyperkeratotic hand eczema</keyword>
	<keyword>vesicular hand eczema</keyword>
	<keyword>pompholyx</keyword>
</DOC>